Céline Bourgne

437 total citations
26 papers, 271 citations indexed

About

Céline Bourgne is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Céline Bourgne has authored 26 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Hematology and 9 papers in Genetics. Recurrent topics in Céline Bourgne's work include Chronic Myeloid Leukemia Treatments (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Myeloid Leukemia Research (3 papers). Céline Bourgne is often cited by papers focused on Chronic Myeloid Leukemia Treatments (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Myeloid Leukemia Research (3 papers). Céline Bourgne collaborates with scholars based in France, United Kingdom and Australia. Céline Bourgne's co-authors include Marc Berger, Bruno Pereira, Florence Brugnon, Hanae Pons‐Rejraji, Juliette Berger, Joël R. Drevet, Sandra Dollet, A. Kocer, Aron Moazamian and L. Janny and has published in prestigious journals such as Blood, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Céline Bourgne

22 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Céline Bourgne France 9 110 65 60 44 42 26 271
Lihong Pang China 12 101 0.9× 51 0.8× 56 0.9× 21 0.5× 21 0.5× 36 376
Xunqiang Yin China 9 126 1.1× 78 1.2× 101 1.7× 25 0.6× 15 0.4× 16 362
Lidija K. Gorsic United States 12 198 1.8× 139 2.1× 124 2.1× 20 0.5× 11 0.3× 14 434
Agnieszka Chrobak Poland 13 136 1.2× 151 2.3× 25 0.4× 58 1.3× 18 0.4× 21 434
Helena Mörse Sweden 10 83 0.8× 65 1.0× 169 2.8× 76 1.7× 9 0.2× 19 312
Siobhan Rice United Kingdom 6 106 1.0× 39 0.6× 64 1.1× 60 1.4× 8 0.2× 11 230
Guiping Wan China 10 136 1.2× 131 2.0× 26 0.4× 13 0.3× 19 0.5× 28 336
Helen A. Lacey United Kingdom 12 188 1.7× 29 0.4× 51 0.8× 19 0.4× 15 0.4× 13 632
Changming Zhang China 9 137 1.2× 19 0.3× 26 0.4× 10 0.2× 57 1.4× 18 352
Katayoon Shirneshan Germany 10 118 1.1× 26 0.4× 79 1.3× 82 1.9× 5 0.1× 21 271

Countries citing papers authored by Céline Bourgne

Since Specialization
Citations

This map shows the geographic impact of Céline Bourgne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Bourgne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Bourgne more than expected).

Fields of papers citing papers by Céline Bourgne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Bourgne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Bourgne. The network helps show where Céline Bourgne may publish in the future.

Co-authorship network of co-authors of Céline Bourgne

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Bourgne. A scholar is included among the top collaborators of Céline Bourgne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Bourgne. Céline Bourgne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bourgne, Céline, et al.. (2025). DNA Methylation in Prostate Cancer: Clinical Implications and Potential Applications. Cancer Medicine. 14(1). e70528–e70528. 3 indexed citations
2.
Bouillon‐Minois, Jean‐Baptiste, et al.. (2025). Contribution of molecular characterization to the diagnosis of MPN in patients with low JAK2V617F variant allelic fraction in a real-world cohort. Annals of Hematology. 104(3). 1587–1596.
3.
Bourgne, Céline, et al.. (2025). P-gp quantification for cell resistance studies in leukemia cells using the innovative LightSpot-FL-1 fluorescent conjugate. Scientific Reports. 15(1). 18173–18173. 1 indexed citations
4.
Parry, Laurent, Céline Jousse, Martin Leremboure, et al.. (2025). Pre-cachectic changes in amino acid homeostasis precede activation of eIF2α signaling in the liver at the onset of C26 cancer-induced cachexia. iScience. 28(3). 112030–112030.
5.
Lazarian, Grégory, Céline Bourgne, Olivier Tournilhac, et al.. (2025). Multiplex digital PCR enables sensitive detection of resistance to BTK inhibitors. Annals of Hematology. 104(5). 2889–2895.
6.
7.
Pons‐Rejraji, Hanae, Sandra Dollet, Céline Bourgne, et al.. (2023). Freezing Does Not Alter Sperm Telomere Length despite Increasing DNA Oxidation and Fragmentation. Genes. 14(5). 1039–1039. 4 indexed citations
8.
Blondonnet, Raïko, Céline Bourgne, Charlotte Leclaire, et al.. (2022). Receptor for Advanced Glycation End-Products Promotes Activation of Alveolar Macrophages through the NLRP3 Inflammasome/TXNIP Axis in Acute Lung Injury. International Journal of Molecular Sciences. 23(19). 11659–11659. 12 indexed citations
9.
Bourgne, Céline, Chinmay Munje, Juliette Berger, et al.. (2022). The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia. Cancers. 14(19). 4695–4695. 3 indexed citations
10.
Bourgne, Céline, et al.. (2021). DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model. Cancers. 13(14). 3587–3587. 10 indexed citations
11.
Pons‐Rejraji, Hanae, Sandra Dollet, Céline Bourgne, et al.. (2021). Beneficial effects of hypotaurine supplementation in preparation and freezing media on human sperm cryo-capacitation and DNA quality. Basic and Clinical Andrology. 31(1). 26–26. 7 indexed citations
12.
Berger, Juliette, Agnès Guerci, Pascale Cony‐Makhoul, et al.. (2021). Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells. Scientific Reports. 11(1). 6187–6187.
13.
Raskovalova, Tatiana, Patrick Deegan, Pramod K. Mistry, et al.. (2020). Accuracy of chitotriosidase activity and CCL18 concentration in assessing type I Gaucher disease severity. A systematic review with meta-analysis of individual participant data. Haematologica. 106(2). 437–445. 20 indexed citations
14.
Biau, J., Émilie Thivat, Emmanuel Chautard, et al.. (2020). Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma. Radiotherapy and Oncology. 154. 227–234. 23 indexed citations
15.
Sinegre, Thomas, et al.. (2020). Impact of Epicatechin on the Procoagulant Activities of Microparticles. Nutrients. 12(10). 2935–2935. 8 indexed citations
16.
Brugnon, Florence, A. Kocer, Sandra Dollet, et al.. (2018). Accuracy of human sperm DNA oxidation quantification and threshold determination using an 8-OHdG immuno-detection assay. Human Reproduction. 33(4). 553–562. 66 indexed citations
17.
Bouvier, Damien, Paul Rouzaire, Matthieu Jabaudon, et al.. (2015). Preanalytical, analytical, gestational and pediatric aspects of the S100B immuno-assays. Clinical Chemistry and Laboratory Medicine (CCLM). 54(5). 833–42. 26 indexed citations
18.
Bourgne, Céline, Juliette Berger, Karin Tarte, et al.. (2014). The Chronic Lymphocytic Leukemia Clone Disrupts the Bone Marrow Microenvironment. Stem Cells and Development. 23(24). 2972–2982. 18 indexed citations
19.
Bourgne, Céline, Juliette Berger, Chantal Rapatel, et al.. (2014). Phosphorylation of spleen tyrosine kinase at tyrosine 348 (pSyk348) may be a marker of advanced phase of Chronic Myeloid Leukemia (CML). Leukemia Research. 39(3). 329–334. 4 indexed citations
20.
Bourgne, Céline, Mahchid Bamdad, F. Libert, et al.. (2012). Measurement of imatinib uptake by flow cytometry. Cytometry Part A. 81A(11). 996–1004. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lihong Pang Breakdown of academic impact, for papers by Xunqiang Yin Breakdown of academic impact, for papers by Lidija K. Gorsic Breakdown of academic impact, for papers by Agnieszka Chrobak Breakdown of academic impact, for papers by Helena Mörse Breakdown of academic impact, for papers by Siobhan Rice Breakdown of academic impact, for papers by Guiping Wan Breakdown of academic impact, for papers by Helen A. Lacey Breakdown of academic impact, for papers by Changming Zhang Breakdown of academic impact, for papers by Katayoon Shirneshan
Rankless by CCL
2026